Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vyant Bio, Inc. (CGIX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vyant Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1349929.
Total stock buying since 2014: $4,451,744.
Total stock sales since 2014: $1,012,092.
Total stock option exercises since 2014: $179,494.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 765 | $1,022 | 0 | $0 |
| 2021 | 103,206 | $276,874 | 0 | $0 | 0 | $0 |
| 2019 | 2,578,915 | $587,150 | 0 | $0 | 0 | $0 |
| 2017 | 371,132 | $1,045,339 | 937 | $3,762 | 937 | $2,342 |
| 2016 | 801,460 | $1,015,839 | 3,333 | $5,192 | 0 | $0 |
| 2015 | 171,000 | $530,511 | 83,333 | $1,002,116 | 0 | $0 |
| 2014 | 133,269 | $996,031 | 0 | $0 | 44,288 | $177,152 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-11 | 0 | $0 | 765 | $1,022 | 0 | $0 |
| 2021-12 | 5,000 | $8,450 | 0 | $0 | 0 | $0 |
| 2021-11 | 10,500 | $21,125 | 0 | $0 | 0 | $0 |
| 2021-10 | 6,000 | $12,690 | 0 | $0 | 0 | $0 |
| 2021-09 | 5,000 | $12,200 | 0 | $0 | 0 | $0 |
| 2021-08 | 36,406 | $87,598 | 0 | $0 | 0 | $0 |
| 2021-07 | 5,000 | $14,625 | 0 | $0 | 0 | $0 |
| 2021-05 | 35,300 | $120,186 | 0 | $0 | 0 | $0 |
| 2019-01 | 2,578,915 | $587,150 | 0 | $0 | 0 | $0 |
| 2017-12 | 162,200 | $303,339 | 0 | $0 | 0 | $0 |
| 2017-08 | 86,185 | $280,704 | 0 | $0 | 0 | $0 |
| 2017-06 | 100,000 | $374,900 | 0 | $0 | 0 | $0 |
| 2017-05 | 22,747 | $86,396 | 937 | $3,762 | 937 | $2,342 |
| 2016-12 | 2,500 | $3,750 | 0 | $0 | 0 | $0 |
| 2016-11 | 136,100 | $199,109 | 3,333 | $5,192 | 0 | $0 |
| 2016-08 | 192,500 | $421,484 | 0 | $0 | 0 | $0 |
| 2016-05 | 317,820 | $0 | 0 | $0 | 0 | $0 |
| 2016-03 | 152,540 | $391,496 | 0 | $0 | 0 | $0 |
| 2015-11 | 105,000 | $0 | 0 | $0 | 0 | $0 |
| 2015-08 | 5,000 | $48,060 | 0 | $0 | 0 | $0 |
| 2015-06 | 0 | $0 | 83,333 | $1,002,116 | 0 | $0 |
| 2015-05 | 10,000 | $107,649 | 0 | $0 | 0 | $0 |
| 2015-03 | 51,000 | $374,802 | 0 | $0 | 0 | $0 |
| 2014-12 | 82,269 | $470,061 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-18 | Harris Geoffrey E. | Sale | 765 | 1.34 | 1,022 |
| 2021-12-06 | Boehm Marcus | Buy | 5,000 | 1.69 | 8,450 |
| 2021-11-24 | Roberts John A (Chief Executive Officer) | Buy | 5,000 | 2.02 | 10,100 |
| 2021-11-23 | Lafrence Andrew D.c. (Chief Financial Officer) | Buy | 5,000 | 2.00 | 10,000 |
| 2021-11-22 | Yeh Yung-ping (Chief Innovation Officer) | Buy | 500 | 2.05 | 1,025 |
| 2021-10-28 | Fremeau Robert Thomas Jr. (Chief Scientific Officer) | Buy | 1,000 | 2.19 | 2,190 |
| 2021-10-27 | Boehm Marcus | Buy | 5,000 | 2.10 | 10,500 |
| 2021-09-29 | Boehm Marcus | Buy | 5,000 | 2.44 | 12,200 |
| 2021-08-25 | Boehm Marcus | Buy | 5,000 | 2.58 | 12,880 |
| 2021-08-25 | Yeh Yung-ping (Chief Innovation Officer) | Buy | 1,000 | 2.64 | 2,640 |
| 2021-08-23 | Roberts John A (Chief Executive Officer) | Buy | 10,406 | 2.41 | 25,078 |
| 2021-08-19 | Hansen Paul R. | Buy | 20,000 | 2.35 | 47,000 |
| 2021-07-28 | Boehm Marcus | Buy | 5,000 | 2.92 | 14,625 |
| 2021-05-28 | Boehm Marcus | Buy | 5,000 | 3.68 | 18,400 |
| 2021-05-24 | Fletcher R John | Buy | 15,300 | 3.39 | 51,836 |
| 2021-05-21 | Fletcher R John | Buy | 15,000 | 3.33 | 49,950 |
| 2019-01-31 | Miles Michael Glenn (Chief Financial Officer) | Buy | 150,000 | .23 | 34,500 |
| 2019-01-31 | Cannon Edmund | Buy | 43,479 | .23 | 10,000 |
| 2019-01-31 | Roberts John A (Chief Executive Officer) | Buy | 185,436 | .23 | 42,650 |
| 2019-01-31 | Pappajohn John | Buy | 1,000,000 | .23 | 230,000 |
| 2019-01-14 | Harris Geoffrey E. | Buy | 100,000 | .23 | 22,500 |
| 2019-01-14 | Roberts John A (Chief Executive Officer) | Buy | 100,000 | .23 | 22,500 |
| 2019-01-14 | Pappajohn John | Buy | 1,000,000 | .23 | 225,000 |
| 2017-12-15 | Roberts John A (Chief Operating Officer) | Buy | 12,200 | 2.00 | 24,339 |
| 2017-12-08 | Pappajohn John | Buy | 150,000 | 1.86 | 279,000 |
| 2017-08-17 | Pappajohn John | Buy | 86,185 | 3.26 | 280,704 |
| 2017-06-12 | Pappajohn John | Buy | 100,000 | 3.75 | 374,900 |
| 2017-05-25 | Gitelman Igor (Chief Accounting Officer) | Buy | 937 | 3.95 | 3,701 |
| 2017-05-23 | Gitelman Igor (Chief Accounting Officer) | Sale | 937 | 4.02 | 3,762 |
| 2017-05-23 | Gitelman Igor (Chief Accounting Officer) | Option Ex | 937 | 2.50 | 2,342 |
| 2017-05-16 | Harris Geoffrey E. | Buy | 2,500 | 3.75 | 9,375 |
| 2017-05-16 | Pappajohn John | Buy | 19,310 | 3.80 | 73,320 |
| 2016-12-14 | Harris Geoffrey E. | Buy | 2,500 | 1.50 | 3,750 |
| 2016-11-28 | Pappajohn John | Buy | 100,000 | 1.45 | 145,300 |
| 2016-11-16 | Sitar Edward J (Chief Financial Officer) | Sale | 3,333 | 1.56 | 5,192 |
| 2016-11-14 | Harris Geoffrey E. | Buy | 5,000 | 1.55 | 7,750 |
| 2016-11-14 | Pappajohn John | Buy | 31,100 | 1.48 | 46,059 |
| 2016-08-16 | Pappajohn John | Buy | 45,000 | 2.29 | 103,185 |
| 2016-08-15 | Pappajohn John | Buy | 79,722 | 2.20 | 175,627 |
| 2016-08-12 | Pappajohn John | Buy | 67,778 | 2.10 | 142,672 |
| 2016-05-25 | Pappajohn John | Buy | 317,820 | .00 | 0 |
| 2016-03-17 | Sharma Panna (Chief Executive Officer) | Buy | 500 | 2.58 | 1,290 |
| 2016-03-17 | Pappajohn John | Buy | 50,000 | 2.64 | 132,050 |
| 2016-03-16 | Welsh Michael J. | Buy | 40 | 2.42 | 96 |
| 2016-03-16 | Sharma Panna (Chief Executive Officer) | Buy | 1,000 | 2.60 | 2,600 |
| 2016-03-16 | Pappajohn John | Buy | 10,579 | 2.62 | 27,738 |
| 2016-03-15 | Sharma Panna (Chief Executive Officer) | Buy | 1,000 | 2.56 | 2,560 |
| 2016-03-15 | Pappajohn John | Buy | 89,421 | 2.52 | 225,162 |
| 2015-11-12 | Sitar Edward J (Chief Financial Officer) | Buy | 5,000 | .00 | 0 |
| 2015-11-12 | Pappajohn John | Buy | 100,000 | .00 | 0 |
| 2015-08-27 | Pappajohn John | Buy | 2,500 | 10.25 | 25,625 |
| 2015-08-26 | Pappajohn John | Buy | 2,500 | 8.97 | 22,435 |
| 2015-06-25 | Chaganti Raju S.k. | Sale | 5,296 | 12.00 | 63,552 |
| 2015-06-12 | Chaganti Raju S.k. | Sale | 7,000 | 12.01 | 84,049 |
| 2015-06-11 | Chaganti Raju S.k. | Sale | 15,900 | 12.04 | 191,515 |
| 2015-06-10 | Chaganti Raju S.k. | Sale | 22,817 | 12.03 | 274,397 |
| 2015-06-09 | Chaganti Raju S.k. | Sale | 7,737 | 12.01 | 92,944 |
| 2015-06-08 | Chaganti Raju S.k. | Sale | 24,583 | 12.03 | 295,659 |
| 2015-05-14 | Harris Geoffrey E. | Buy | 5,000 | 10.79 | 53,949 |
| 2015-05-14 | Pappajohn John | Buy | 5,000 | 10.74 | 53,700 |
| 2015-03-17 | Pappajohn John | Buy | 15,000 | 7.15 | 107,235 |
| 2015-03-16 | Sitar Edward J (Chief Financial Officer) | Buy | 1,000 | 6.99 | 6,992 |
| 2015-03-16 | Pappajohn John | Buy | 35,000 | 7.45 | 260,575 |
| 2014-12-16 | Pappajohn John | Buy | 5,589 | 6.20 | 34,651 |
| 2014-12-15 | Pappajohn John | Buy | 3,634 | 6.14 | 22,312 |
| 2014-12-12 | Sitar Edward J (Chief Financial Officer) | Buy | 500 | 6.26 | 3,130 |
| 2014-12-11 | Pappajohn John | Buy | 27,087 | 6.03 | 163,334 |
| 2014-12-10 | Pappajohn John | Buy | 5,773 | 5.96 | 34,407 |
| 2014-12-09 | Pappajohn John | Buy | 15,986 | 5.70 | 91,120 |
| 2014-12-08 | Pappajohn John | Buy | 23,700 | 5.11 | 121,107 |
| 2014-06-10 | Pappajohn John | Option Ex | 44,288 | 4.00 | 177,152 |
| 2014-05-21 | Sitar Edward J (Chief Financial Officer) | Buy | 1,000 | 10.67 | 10,670 |
| 2014-05-21 | Pappajohn John | Buy | 5,000 | 10.66 | 53,300 |
| 2014-05-20 | Pappajohn John | Buy | 30,000 | 10.35 | 310,500 |
| 2014-05-19 | Pappajohn John | Buy | 15,000 | 10.10 | 151,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of CGIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vyant Bio, Inc. (symbol CGIX, CIK number 1349929) see the Securities and Exchange Commission (SEC) website.